<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance:</title><copyright>Copyright (c) 2010 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com</link><description>Latest Financial News</description><language>en-us</language><lastBuildDate>Thu, 24 Dec 2009 11:08:27 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>NEUROGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Dispositio (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091224/nrgn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2796358929</guid><pubDate>Thu, 24 Dec 2009 11:08:27 Etc/GMT</pubDate></item><item><title>Ligand Completes Neurogen Acquisition (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091223/20091223005573.html?.v=1</link><description>SAN DIEGO----Ligand Pharmaceuticals Incorporated announced today that it has completed the acquisition of Neurogen Corporation , following approval of the transaction by Neurogen stockholders earlier today.</description><guid isPermaLink="false">yahoo_finance/2143220139</guid><pubDate>Wed, 23 Dec 2009 22:00:00 Etc/GMT</pubDate></item><item><title>Ligand adds cash to Neurogen buyout (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_ligand_neurogen_acquisition.html?.v=1</link><description>Ligand Pharmaceuticals Inc. said Thursday it amended a deal to buy Neurogen Corp., adding $600,000 in cash to stockholders.</description><guid isPermaLink="false">yahoo_finance/1480597839</guid><pubDate>Thu, 17 Dec 2009 21:16:53 Etc/GMT</pubDate></item><item><title>Neurogen Corporation Receives Notice from NASDAQ Regarding Listing of Securities (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091217/20091217006289.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4069141476</guid><pubDate>Thu, 17 Dec 2009 21:12:00 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091217/nrgn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2228554243</guid><pubDate>Thu, 17 Dec 2009 18:14:28 Etc/GMT</pubDate></item><item><title>Ligand and Neurogen Amend Merger Agreement (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091217/20091217005969.html?.v=1</link><description>SAN DIEGO &amp; BRANFORD, Conn.----Ligand Pharmaceuticals Incorporated and Neurogen Corporation announced today they have amended their merger agreement to increase the merger consideration payable.</description><guid isPermaLink="false">yahoo_finance/962673216</guid><pubDate>Thu, 17 Dec 2009 17:32:00 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091118/nrgn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3343843063</guid><pubDate>Wed, 18 Nov 2009 20:58:45 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=nrgn</link><description></description><guid isPermaLink="false">yahoo_finance/1155987639</guid><pubDate>Fri, 13 Nov 2009 14:05:37 Etc/GMT</pubDate></item><item><title>New Star Analyst Rankings for Neurogen Corporation (StarMine)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/n/nrgn.html</link><description></description><guid isPermaLink="false">yahoo_finance/1843062970</guid><pubDate>Tue, 10 Nov 2009 14:24:52 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Files SEC form 10-Q/A, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091109/nrgn10-q_a.html</link><description></description><guid isPermaLink="false">yahoo_finance/3499254158</guid><pubDate>Mon, 9 Nov 2009 17:50:43 Etc/GMT</pubDate></item><item><title>Neurogen Corporation Earnings Call scheduled for 8:30 am ET today (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/5/109225.html</link><description></description><guid isPermaLink="false">yahoo_finance/3066146843</guid><pubDate>Fri, 6 Nov 2009 13:30:00 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial Con (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091106/nrgn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/3082399148</guid><pubDate>Fri, 6 Nov 2009 12:16:18 Etc/GMT</pubDate></item><item><title>Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091106/20091106005102.html?.v=1</link><description>BRANFORD, Conn.----Neurogen Corporation , a drug development company historically focused on drugs for psychiatric and neurological disorders, today announced financial and operating results for the quarter ended September 30, 2009.</description><guid isPermaLink="false">yahoo_finance/4252056039</guid><pubDate>Fri, 6 Nov 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Neurogen Corporation Announces Webcast of Third Quarter 2009 Financial Results on November 6 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091104/20091104006470.html?.v=1</link><description>BRANFORD, Conn.----Neurogen Corporation , a drug development company, announced today that it will release its third quarter 2009 financial results on Friday, November 6, 2009 before the opening of the U.S. financial markets.</description><guid isPermaLink="false">yahoo_finance/1052186416</guid><pubDate>Wed, 4 Nov 2009 21:41:00 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Sta (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090824/nrgn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1794988338</guid><pubDate>Mon, 24 Aug 2009 19:57:02 Etc/GMT</pubDate></item><item><title>Neurogen Corporation Earnings Call scheduled for 5:00 pm ET today (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/3/106903.html</link><description></description><guid isPermaLink="false">yahoo_finance/1592081563</guid><pubDate>Fri, 14 Aug 2009 21:00:00 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090814/nrgn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2303385933</guid><pubDate>Fri, 14 Aug 2009 20:29:11 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090515/nrgn10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/2736156494</guid><pubDate>Fri, 15 May 2009 20:05:42 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit or Dispos (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090512/nrgn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/423567112</guid><pubDate>Tue, 12 May 2009 11:14:26 Etc/GMT</pubDate></item><item><title>NEUROGEN CORP Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090507/nrgn8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/2348249166</guid><pubDate>Thu, 7 May 2009 20:45:39 Etc/GMT</pubDate></item></channel></rss><!-- c20.finance.sp2.yahoo.com compressed/chunked Thu Jan  7 04:52:46 PST 2010 -->
